Vivanza Biosciences Limited reported unaudited consolidated and standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, on standalone basis, the company reported revenue from operations of INR 19.979 million against INR 4.831 million a year ago. Profit before exceptional items and tax was INR 0.882 million against loss before exceptional items and tax of INR 1.689 million a year ago. Profit before tax was INR 0.882 million against loss before tax of INR 1.689 million a year ago. Profit for the period from continuing operations was INR 0.882 million or INR 0.22 per basic and diluted share before and after extraordinary items (not annualized) against loss for the period from continuing operations of INR 1.689 million or INR 0.66 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the nine months, on standalone basis, the company reported revenue from operations of INR 52.178 million against INR 9.486 million a year ago. Profit before exceptional items and tax was INR 1.906 million against loss before exceptional items and tax of INR 3.538 million a year ago. Profit before tax was INR 1.906 million against loss before tax of INR 3.538 million a year ago. Profit for the period from continuing operations was INR 1.906 million or INR 0.48 per basic and diluted share before and after extraordinary items (not annualized) against loss for the period from continuing operations of INR 3.538 million or INR 1.39 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the quarter, on consolidated basis, the company reported revenue from operations of INR 19.979 million against INR 4.816 million a year ago. Profit before exceptional items and tax was INR 0.783 million against loss before exceptional items and tax of INR 1.993 million a year ago. Profit before tax was INR 0.783 million against loss before tax of INR 1.993 million a year ago. Profit for the period from continuing operations was INR 0.783 million or INR 0.20 per basic and diluted share before and after extraordinary items (not annualized) against loss for the period from continuing operations of INR 1.993 million or INR 0.78 per basic and diluted share before and after extraordinary items (not annualized) a year ago. For the nine months, on consolidated basis, the company reported revenue from operations of INR 52.178 million against INR 9.486 million a year ago. Profit before exceptional items and tax was INR 1.616 million against loss before exceptional items and tax of INR 4.395 million a year ago. Profit before tax was INR 1.616 million against loss before tax of INR 4.395 million a year ago. Profit for the period from continuing operations was INR 1.616 million or INR 0.40 per basic and diluted share before and after extraordinary items (not annualized) against loss for the period from continuing operations of INR 4.395 million or INR 1.72 per basic and diluted share before and after extraordinary items (not annualized) a year ago.